OpenURL Connection Search

Select item for more details and to access through your institution.

Amplification Target ADRM1: Role as an Oncogene and Therapeutic Target for Ovarian Cancer.
Published in:
International Journal of Molecular Sciences, 2013, v. 14, n. 2, p. 3094, doi. 10.3390/ijms14023094
By:
- Fejzo, Marlena S.;
- Anderson, Lee;
- Euw, Erika M. von;
- Kalous, Ondrej;
- Avliyakulov, Nuraly K.;
- Haykinson, Michael J.;
- Konecny, Gottfried E.;
- Finn, Richard S.;
- Slamon, Dennis J.
Publication type:
Article
Targeting vascular endothelial growth factor with the monoclonal antibody bevacizumab inhibits human hepatocellular carcinoma cells growing in an orthotopic mouse model.
Published in:
Liver International, 2009, v. 29, n. 2, p. 284, doi. 10.1111/j.1478-3231.2008.01762.x
By:
- Finn, Richard S.;
- Bentley, Greg;
- Britten, Carolyn D.;
- Amado, Rafael;
- Busuttil, Ronald W.
Publication type:
Article
Treatment effect of palbociclib plus endocrine therapy by prognostic and intrinsic subtype and biomarker analysis in patients with bone-only disease: a joint analysis of PALOMA-2 and PALOMA-3 clinical trials.
Published in:
Breast Cancer Research & Treatment, 2020, v. 184, n. 1, p. 23, doi. 10.1007/s10549-020-05782-4
By:
- Finn, Richard S.;
- Cristofanilli, Massimo;
- Ettl, Johannes;
- Gelmon, Karen A.;
- Colleoni, Marco;
- Giorgetti, Carla;
- Gauthier, Eric;
- Liu, Yuan;
- Lu, Dongrui R.;
- Zhang, Zhe;
- Bartlett, Cynthia Huang;
- Slamon, Dennis J.;
- Turner, Nicholas C.;
- Rugo, Hope S.
Publication type:
Article
Overall survival results from the randomized phase 2 study of palbociclib in combination with letrozole versus letrozole alone for first-line treatment of ER+/HER2− advanced breast cancer (PALOMA-1, TRIO-18).
Published in:
Breast Cancer Research & Treatment, 2020, v. 183, n. 2, p. 419, doi. 10.1007/s10549-020-05755-7
By:
- Finn, Richard S.;
- Boer, Katalin;
- Bondarenko, Igor;
- Patel, Ravindranath;
- Pinter, Tamas;
- Schmidt, Marcus;
- Shparyk, Yaroslav V.;
- Thummala, Anu;
- Voitko, Nataliia;
- Bananis, Eustratios;
- McRoy, Lynn;
- Wilner, Keith;
- Huang, Xin;
- Kim, Sindy;
- Slamon, Dennis J.;
- Ettl, Johannes
Publication type:
Article
The impact of ethnicity on efficacy and toxicity of cyclin D kinase 4/6 inhibitors in advanced breast cancer: a meta-analysis.
Published in:
Breast Cancer Research & Treatment, 2019, v. 174, n. 1, p. 271, doi. 10.1007/s10549-018-5054-x
By:
- Lee, Kirsty Wai Chung;
- Lord, Sally;
- Finn, Richard S.;
- Lim, Elgene;
- Martin, Andrew;
- Loi, Sherene;
- Lynch, Jodi;
- Friedlander, Michael;
- Lee, Chee Khoon
Publication type:
Article
Covalent Chemistry‐Mediated Multimarker Purification of Circulating Tumor Cells Enables Noninvasive Detection of Molecular Signatures of Hepatocellular Carcinoma.
Published in:
Advanced Materials Technologies, 2021, v. 6, n. 5, p. 1, doi. 10.1002/admt.202001056
By:
- Sun, Na;
- Lee, Yi‐Te;
- Kim, Minhyung;
- Wang, Jasmine J.;
- Zhang, Ceng;
- Teng, Pai‐Chi;
- Qi, Dongping;
- Zhang, Ryan Y.;
- Tran, Benjamin V.;
- Lee, Yue Tung;
- Ye, Jinglei;
- Palomique, Juvelyn;
- Nissen, Nicholas N.;
- Han, Steven‐Huy B.;
- Sadeghi, Saeed;
- Finn, Richard S.;
- Saab, Sammy;
- Busuttil, Ronald W.;
- Posadas, Edwin M.;
- Liang, Li
Publication type:
Article
Ramucirumab in patients with advanced hepatocellular carcinoma and elevated α‐fetoprotein: Outcomes by treatment‐emergent ascites.
Published in:
Hepatology Research, 2021, v. 51, n. 6, p. 715, doi. 10.1111/hepr.13638
By:
- Kudo, Masatoshi;
- Ikeda, Masafumi;
- Galle, Peter R.;
- Yamashita, Tatsuya;
- Finn, Richard S.;
- Liang, Kun;
- Wang, Chunxiao;
- Sakaguchi, Sachi;
- Abada, Paolo;
- Widau, Ryan C.;
- Zhu, Andrew X.
Publication type:
Article
New Horizons in the Treatment and Management of Hepatocellular Carcinoma: Expert Perspectives on the Evolving Role of Immunotherapy.
Published in:
Journal of Managed Care Medicine, 2021, v. 24, n. 4, p. 31
By:
- Finn, Richard S.
Publication type:
Article
ALBI score and outcomes in patients with hepatocellular carcinoma: post hoc analysis of the randomized controlled trial KEYNOTE-240.
Published in:
Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/17588359211039928
By:
- Vogel, Arndt;
- Merle, Philippe;
- Verslype, Chris;
- Finn, Richard S.;
- Zhu, Andrew X.;
- Cheng, Ann-Lii;
- Chan, Stephen Lam;
- Yau, Thomas;
- Ryoo, Baek-Yeol;
- Knox, Jennifer;
- Daniele, Bruno;
- Qin, Shukui;
- Wei, Ziwen;
- Miteva, Yanna;
- Malhotra, Usha;
- Siegel, Abby B.;
- Kudo, Masatoshi
Publication type:
Article
ALBI score and outcomes in patients with hepatocellular carcinoma: post hoc analysis of the randomized controlled trial KEYNOTE-240.
Published in:
Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/17588359211039928
By:
- Vogel, Arndt;
- Merle, Philippe;
- Verslype, Chris;
- Finn, Richard S.;
- Zhu, Andrew X.;
- Cheng, Ann-Lii;
- Chan, Stephen Lam;
- Yau, Thomas;
- Ryoo, Baek-Yeol;
- Knox, Jennifer;
- Daniele, Bruno;
- Qin, Shukui;
- Wei, Ziwen;
- Miteva, Yanna;
- Malhotra, Usha;
- Siegel, Abby B.;
- Kudo, Masatoshi
Publication type:
Article
Comparative effectiveness of first-line palbociclib plus letrozole versus letrozole alone for HR+/HER2- metastatic breast cancer in US real-world clinical practice.
Published in:
2021
By:
- DeMichele, Angela;
- Cristofanilli, Massimo;
- Brufsky, Adam;
- Liu, Xianchen;
- Mardekian, Jack;
- McRoy, Lynn;
- Layman, Rachel M.;
- Emir, Birol;
- Torres, Mylin A.;
- Rugo, Hope S.;
- Finn, Richard S.
Publication type:
journal article
Hematologic adverse events following palbociclib dose reduction in patients with hormone receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer: pooled analysis from randomized phase 2 and 3 studies.
Published in:
2020
By:
- Ettl, Johannes;
- Im, Seock-Ah;
- Ro, Jungsil;
- Masuda, Norikazu;
- Colleoni, Marco;
- Schnell, Patrick;
- Bananis, Eustratios;
- Lu, Dongrui R.;
- Cristofanilli, Massimo;
- Rugo, Hope S.;
- Finn, Richard S.
Publication type:
journal article
Dacomitinib, an Irreversible Pan-ErbB Inhibitor Significantly Abrogates Growth in Head and Neck Cancer Models That Exhibit Low Response to Cetuximab.
Published in:
PLoS ONE, 2013, v. 8, n. 2, p. 1, doi. 10.1371/journal.pone.0056112
By:
- Ather, Ferdows;
- Hamidi, Habib;
- Fejzo, Marlena S.;
- Letrent, Stephen;
- Finn, Richard S.;
- Kabbinavar, Fairooz;
- Head, Christian;
- Wong, Steven G.
Publication type:
Article
Indirect Treatment Comparison of First-Line CDK4/6-Inhibitors in Post-Menopausal Patients with HR+/HER2− Metastatic Breast Cancer.
Published in:
Cancers, 2023, v. 15, n. 18, p. 4558, doi. 10.3390/cancers15184558
By:
- Zhao, Joseph J.;
- Fong, Khi Yung;
- Chan, Yiong Huak;
- Tey, Jeremy;
- Dawood, Shaheenah;
- Lee, Soo Chin;
- Finn, Richard S.;
- Sundar, Raghav;
- Lim, Joline S. J.
Publication type:
Article
Ramucirumab in patients with previously treated advanced hepatocellular carcinoma: Impact of liver disease aetiology.
Published in:
Liver International, 2021, v. 41, n. 11, p. 2759, doi. 10.1111/liv.14994
By:
- Galle, Peter R.;
- Kudo, Masatoshi;
- Llovet, Josep M.;
- Finn, Richard S.;
- Karwal, Mark;
- Pezet, Denis;
- Kim, Tae‐You;
- Yang, Tsai‐Sheng;
- Lonardi, Sara;
- Tomasek, Jiri;
- Phelip, Jean‐Marc;
- Touchefeu, Yann;
- Koh, Su‐Jin;
- Stirnimann, Guido;
- Liang, Kun;
- Ogburn, Kenyon D.;
- Wang, Chunxiao;
- Abada, Paolo;
- Widau, Ryan C.;
- Zhu, Andrew X.
Publication type:
Article
Ramucirumab in elderly patients with hepatocellular carcinoma and elevated alpha‐fetoprotein after sorafenib in REACH and REACH‐2.
Published in:
Liver International, 2020, v. 40, n. 8, p. 2008, doi. 10.1111/liv.14462
By:
- Kudo, Masatoshi;
- Galle, Peter R.;
- Llovet, Josep M.;
- Finn, Richard S.;
- Vogel, Arndt;
- Motomura, Kenta;
- Assenat, Eric;
- Merle, Philippe;
- Brandi, Giovanni;
- Daniele, Bruno;
- Okusaka, Takuji;
- Tomášek, Jiří;
- Borg, Christophe;
- Dadduzio, Vincenzo;
- Morimoto, Manabu;
- Pracht, Marc;
- Jen, Min‐Hua;
- Drove Ubreva, Nora;
- Widau, Ryan C.;
- Shinozaki, Kenta
Publication type:
Article
Impact of Bevacizumab Being Skipped due to Adverse Events of Special Interest for Bevacizumab in Patients with Unresectable Hepatocellular Carcinoma Treated with Atezolizumab plus Bevacizumab: An Exploratory Analysis of the Phase III IMbrave150 Study.
Published in:
Liver Cancer (2235-1795), 2024, v. 13, n. 4, p. 401, doi. 10.1159/000535501
By:
- Kudo, Masatoshi;
- Tsuchiya, Kaoru;
- Shao, Yu-Yun;
- Finn, Richard S.;
- Galle, Peter R.;
- Ducreux, Michel;
- Cheng, Ann-Lii;
- Yamashita, Tatsuya;
- Koga, Hironori;
- Take, Ryosuke;
- Yamada, Kyoko;
- Asakawa, Takashi;
- Nakagawa, Yuki;
- Ikeda, Masafumi
Publication type:
Article
Tislelizumab versus Sorafenib in First-Line Treatment of Unresectable Hepatocellular Carcinoma: Impact on Health-Related Quality of Life in RATIONALE-301 Study.
Published in:
Liver Cancer (2235-1795), 2024, v. 13, n. 5, p. 548, doi. 10.1159/000537966
By:
- Finn, Richard S.;
- Kudo, Masatoshi;
- Barnes, Gisoo;
- Meyer, Tim;
- Boisserie, Frederic;
- Abdrashitov, Ramil;
- Chen, Yaxi;
- Li, Songzi;
- Zhu, Andrew X.;
- Qin, Shukui;
- Vogel, Arndt
Publication type:
Article
Characterization of Tumor Responses in Patients with Unresectable Hepatocellular Carcinoma Treated with Lenvatinib in the Phase 3 Randomized Trial: REFLECT.
Published in:
Liver Cancer (2235-1795), 2024, v. 13, n. 5, p. 537, doi. 10.1159/000537947
By:
- Finn, Richard S.;
- Qin, Shukui;
- Piscaglia, Fabio;
- Evans, Thomas R. Jeffry;
- Knox, Jennifer J.;
- López López, Carlos;
- Ramji, Zahra;
- Ren, Min;
- Mody, Kalgi;
- Vogel, Arndt;
- Kudo, Masatoshi
Publication type:
Article
A Phase 1b Study of Lenvatinib plus Pembrolizumab in Patients with Unresectable Hepatocellular Carcinoma: Extended Analysis of Study 116.
Published in:
Liver Cancer (2235-1795), 2024, v. 13, n. 4, p. 451, doi. 10.1159/000535154
By:
- Kudo, Masatoshi;
- Finn, Richard S.;
- Ikeda, Masafumi;
- Sung, Max W.;
- Baron, Ari D.;
- Okusaka, Takuji;
- Kobayashi, Masahiro;
- Kumada, Hiromitsu;
- Kaneko, Shuichi;
- Pracht, Marc;
- Meyer, Tim;
- Nagao, Satoshi;
- Saito, Kenichi;
- Mody, Kalgi;
- Ramji, Zahra;
- Dubrovsky, Leonid;
- Llovet, Josep M.
Publication type:
Article
Atezolizumab in Combination with Bevacizumab for the Management of Patients with Hepatocellular Carcinoma in the First-Line Setting: Systematic Literature Review and Meta-Analysis.
Published in:
Liver Cancer (2235-1795), 2023, v. 12, n. 6, p. 510, doi. 10.1159/000533166
By:
- Vogel, Arndt;
- Finn, Richard S.;
- Blanchet Zumofen, Marie-Hélène;
- Heuser, Carolina;
- Sanchez Alvarez, Javier;
- Leibfried, Michael;
- Mitchell, Catherine R.;
- Batson, Sarah;
- Redhead, Gabrielle;
- Gaillard, Vincent E.;
- Kudo, Masatoshi
Publication type:
Article
Pembrolizumab as Second-Line Therapy for Advanced Hepatocellular Carcinoma: Longer Term Follow-Up from the Phase 3 KEYNOTE-240 Trial.
Published in:
Liver Cancer (2235-1795), 2023, v. 12, n. 4, p. 309, doi. 10.1159/000529636
By:
- Merle, Philippe;
- Kudo, Masatoshi;
- Edeline, Julien;
- Bouattour, Mohamed;
- Cheng, Ann-Lii;
- Chan, Stephen Lam;
- Yau, Thomas;
- Garrido, Marcelo;
- Knox, Jennifer;
- Daniele, Bruno;
- Breder, Valeriy;
- Lim, Ho Yeong;
- Ogasawara, Sadahisa;
- Cattan, Stéphane;
- Chao, Yee;
- Siegel, Abby B.;
- Martinez-Forero, Iván;
- Wei, Ziwen;
- Liu, Chih-Chin;
- Finn, Richard S.
Publication type:
Article
Albumin-Bilirubin Grade Analyses of Atezolizumab plus Bevacizumab versus Sorafenib in Patients with Unresectable Hepatocellular Carcinoma: A Post Hoc Analysis of the Phase III IMbrave150 Study.
Published in:
Liver Cancer (2235-1795), 2023, v. 12, n. 5, p. 479, doi. 10.1159/000529996
By:
- Kudo, Masatoshi;
- Finn, Richard S.;
- Cheng, Ann-Lii;
- Zhu, Andrew X.;
- Ducreux, Michel;
- Galle, Peter R.;
- Sakamoto, Naoya;
- Kato, Naoya;
- Nakano, Michitaka;
- Jia, Jing;
- Vogel, Arndt
Publication type:
Article
IMbrave150: Efficacy and Safety of Atezolizumab plus Bevacizumab versus Sorafenib in Patients with Barcelona Clinic Liver Cancer Stage B Unresectable Hepatocellular Carcinoma: An Exploratory Analysis of the Phase III Study.
Published in:
Liver Cancer (2235-1795), 2023, v. 12, n. 3, p. 238, doi. 10.1159/000528272
By:
- Kudo, Masatoshi;
- Finn, Richard S.;
- Galle, Peter R.;
- Zhu, Andrew X.;
- Ducreux, Michel;
- Cheng, Ann-Lii;
- Ikeda, Masafumi;
- Tsuchiya, Kaoru;
- Aoki, Ken-ichi;
- Jia, Jing;
- Lencioni, Riccardo
Publication type:
Article
Hepatic Events and Viral Kinetics in Hepatocellular Carcinoma Patients Treated with Atezolizumab plus Bevacizumab.
Published in:
Liver Cancer (2235-1795), 2023, v. 12, n. 1, p. 44, doi. 10.1159/000525499
By:
- Hsu, Chiun;
- Ducreux, Michel;
- Zhu, Andrew X.;
- Qin, Shukui;
- Ikeda, Masafumi;
- Kim, Tae-You;
- Galle, Peter R.;
- Finn, Richard S.;
- Chen, Ethan;
- Ma, Ning;
- Hu, Youyou;
- Li, Lindong;
- Cheng, Ann-Lii
Publication type:
Article
Ramucirumab for Patients with Intermediate-Stage Hepatocellular Carcinoma and Elevated Alpha-Fetoprotein: Pooled Results from Two Phase 3 Studies (REACH and REACH-2).
Published in:
Liver Cancer (2235-1795), 2021, v. 10, n. 5, p. 451, doi. 10.1159/000516605
By:
- Kudo, Masatoshi;
- Finn, Richard S.;
- Morimoto, Manabu;
- Rau, Kun-Ming;
- Ikeda, Masafumi;
- Yen, Chia-Jui;
- Galle, Peter R.;
- Llovet, Josep M.;
- Daniele, Bruno;
- Lim, Ho Yeong;
- McIlwain, David W.;
- Yoshikawa, Reigetsu;
- Nakamura, Kenichi;
- Liang, Kun;
- Wang, Chunxiao;
- Abada, Paolo;
- Widau, Ryan C.;
- Zhu, Andrew X.
Publication type:
Article
Ramucirumab for Patients with Intermediate-Stage Hepatocellular Carcinoma and Elevated Alpha-Fetoprotein: Pooled Results from Two Phase 3 Studies (REACH and REACH-2).
Published in:
Liver Cancer (2235-1795), 2021, v. 10, n. 5, p. 451, doi. 10.1159/000516605
By:
- Kudo, Masatoshi;
- Finn, Richard S.;
- Morimoto, Manabu;
- Rau, Kun-Ming;
- Ikeda, Masafumi;
- Yen, Chia-Jui;
- Galle, Peter R.;
- Llovet, Josep M.;
- Daniele, Bruno;
- Lim, Ho Yeong;
- McIlwain, David W.;
- Yoshikawa, Reigetsu;
- Nakamura, Kenichi;
- Liang, Kun;
- Wang, Chunxiao;
- Abada, Paolo;
- Widau, Ryan C.;
- Zhu, Andrew X.
Publication type:
Article
Bilateral Subfoveal Neurosensory Retinal Detachment Associated With MEK Inhibitor Use for Metastatic Cancer.
Published in:
JAMA Ophthalmology, 2014, v. 132, n. 8, p. 1005, doi. 10.1001/jamaophthalmol.2014.976
By:
- McCannel, Tara A.;
- Chmielowski, Bartosz;
- Finn, Richard S.;
- Goldman, Jonathan;
- Ribas, Antoni;
- Wainberg, Zev A.;
- McCannel, Colin A.
Publication type:
Article
Biologic effects of heregulin/neu differentiation factor on normal and malignant human breast and ovarian epithelial cells.
Published in:
Oncogene, 1999, v. 18, n. 44, p. 6050, doi. 10.1038/sj.onc.1202993
By:
- Aguilar, Zuleima;
- Akita, Robert W;
- Finn, Richard S;
- Ramos, B Lillian;
- Pegram, Mark D;
- Kabbinavar, Fairooz F;
- Pietras, Richard J;
- Pisacane, Paul;
- Sliwkowski, Mark X;
- Slamon, Dennis J
Publication type:
Article
Remission of human breast cancer xenografts on therapy with humanized monoclonal antibody to HER-2 receptor and DNA-reactive drugs.
Published in:
Oncogene, 1998, v. 17, n. 17, p. 2235, doi. 10.1038/sj.onc.1202132
By:
- Pietras, Richard J;
- Pegram, Mark D;
- Finn, Richard S;
- Maneval, Daniel A;
- Slamon, Dennis J
Publication type:
Article
The effect of HER-2/neu overexpression on chemotherapeutic drug sensitivity in human breast and ovarian cancer cells.
Published in:
Oncogene, 1997, v. 15, n. 5, p. 537, doi. 10.1038/sj.onc.1201222
By:
- Pegram, Mark D;
- Finn, Richard S;
- Arzoo, Karo;
- Beryt, Malgorzata;
- Pietras, Richard J;
- Slamon, Dennis J
Publication type:
Article
Efficacy and safety of palbociclib in combination with letrozole as first-line treatment of ER-positive, HER2-negative, advanced breast cancer: expanded analyses of subgroups from the randomized pivotal trial PALOMA-1/TRIO-18.
Published in:
2016
By:
- Finn, Richard S.;
- Crown, John P.;
- Ettl, Johannes;
- Schmidt, Marcus;
- Bondarenko, Igor M.;
- Lang, Istvan;
- Pinter, Tamas;
- Boer, Katalin;
- Patel, Ravindranath;
- Randolph, Sophia;
- Kim, Sindy T.;
- Xin Huang;
- Schnell, Patrick;
- Nadanaciva, Sashi;
- Bartlett, Cynthia Huang;
- Slamon, Dennis J.;
- Huang, Xin
Publication type:
journal article
Targeting the cyclin-dependent kinases (CDK) 4/6 in estrogen receptor-positive breast cancers.
Published in:
2016
By:
- Finn, Richard S.;
- Aleshin, Alexey;
- Slamon, Dennis J.
Publication type:
journal article
Review of Regorafenib for the Treatment of Hepatocellular Carcinoma.
Published in:
Gastroenterology & Hepatology, 2017, v. 13, n. 8, p. 492
By:
- Finn, Richard S.
Publication type:
Article
Treatment of Intermediate-Stage Hepatocellular Carcinoma.
Published in:
2015
By:
- Finn, Richard S.
Publication type:
Interview
Correction: Urine protein:creatinine ratio vs 24-hour urine protein for proteinuria management: analysis from the phase 3 REFLECT study of lenvatinib vs sorafenib in hepatocellular carcinoma.
Published in:
2019
By:
- Evans, Thomas R. Jeffry;
- Kudo, Masatoshi;
- Finn, Richard S.;
- Han, Kwang-Hyub;
- Cheng, Ann-Lii;
- Ikeda, Masafumi;
- Kraljevic, Silvija;
- Ren, Min;
- Dutcus, Corina E.;
- Piscaglia, Fabio;
- Sung, Max W.
Publication type:
corrected article
Urine protein:creatinine ratio vs 24-hour urine protein for proteinuria management: analysis from the phase 3 REFLECT study of lenvatinib vs sorafenib in hepatocellular carcinoma.
Published in:
2019
By:
- Evans, Thomas R. Jeffry;
- Kudo, Masatoshi;
- Finn, Richard S.;
- Han, Kwang-Hyub;
- Cheng, Ann-Lii;
- Ikeda, Masafumi;
- Kraljevic, Silvija;
- Ren, Min;
- Dutcus, Corina E.;
- Piscaglia, Fabio;
- Sung, Max W.
Publication type:
journal article
A phase 1 dose-escalation and expansion study of binimetinib (MEK162), a potent and selective oral MEK1/2 inhibitor.
Published in:
2017
By:
- Bendell, Johanna C;
- Javle, Milind;
- Bekaii-Saab, Tanios S;
- Finn, Richard S;
- Wainberg, Zev A;
- Laheru, Daniel A;
- Weekes, Colin D;
- Tan, Benjamin R;
- Khan, Gazala N;
- Zalupski, Mark M;
- Infante, Jeffrey R;
- Jones, Suzanne;
- Papadopoulos, Kyriakos P;
- Tolcher, Anthony W;
- Chavira, Renae E;
- Christy-Bittel, Janna L;
- Barrett, Emma;
- Patnaik, Amita
Publication type:
journal article
Randomized Phase 3 LEAP-012 Study: Transarterial Chemoembolization With or Without Lenvatinib Plus Pembrolizumab for Intermediate-Stage Hepatocellular Carcinoma Not Amenable to Curative Treatment.
Published in:
CardioVascular & Interventional Radiology, 2022, v. 45, n. 4, p. 405, doi. 10.1007/s00270-021-03031-9
By:
- Llovet, Josep M.;
- Vogel, Arndt;
- Madoff, David C.;
- Finn, Richard S.;
- Ogasawara, Sadahisa;
- Ren, Zhenggang;
- Mody, Kalgi;
- Li, Jerry J.;
- Siegel, Abby B.;
- Dubrovsky, Leonid;
- Kudo, Masatoshi
Publication type:
Article
Serum alpha-fetoprotein and clinical outcomes in patients with advanced hepatocellular carcinoma treated with ramucirumab.
Published in:
2021
By:
- Zhu, Andrew X.;
- Finn, Richard S.;
- Kang, Yoon-Koo;
- Yen, Chia-Jui;
- Galle, Peter R.;
- Llovet, Josep M.;
- Assenat, Eric;
- Brandi, Giovanni;
- Motomura, Kenta;
- Ohno, Izumi;
- Daniele, Bruno;
- Vogel, Arndt;
- Yamashita, Tatsuya;
- Hsu, Chih-Hung;
- Gerken, Guido;
- Bilbruck, John;
- Hsu, Yanzhi;
- Liang, Kun;
- Widau, Ryan C.;
- Wang, Chunxiao
Publication type:
journal article
Comparative biomarker analysis of PALOMA-2/3 trials for palbociclib.
Published in:
NPJ Precision Oncology, 2022, v. 6, n. 1, p. 1, doi. 10.1038/s41698-022-00297-1
By:
- Zhu, Zhou;
- Turner, Nicholas C.;
- Loi, Sherene;
- André, Fabrice;
- Martin, Miguel;
- Diéras, Véronique;
- Gelmon, Karen A.;
- Harbeck, Nadia;
- Zhang, Cathy;
- Cao, Joan Q.;
- Yan, Zhengming;
- Lu, Dongrui R.;
- Wei, Ping;
- VanArsdale, Todd L.;
- Rejto, Paul A.;
- Huang, Xin;
- Rugo, Hope S.;
- Loibl, Sibylle;
- Cristofanilli, Massimo;
- Finn, Richard S.
Publication type:
Article
Somatic copy number profiling from hepatocellular carcinoma circulating tumor cells.
Published in:
NPJ Precision Oncology, 2020, v. 4, n. 1, p. 1, doi. 10.1038/s41698-020-0123-0
By:
- Court, Colin M.;
- Hou, Shuang;
- Liu, Lian;
- Winograd, Paul;
- DiPardo, Benjamin J.;
- Liu, Sean X.;
- Chen, Pin-Jung;
- Zhu, Yazhen;
- Smalley, Matthew;
- Zhang, Ryan;
- Sadeghi, Saeed;
- Finn, Richard S.;
- Kaldas, Fady M.;
- Busuttil, Ronald W.;
- Zhou, Xianghong J.;
- Tseng, Hsian-Rong;
- Tomlinson, James S.;
- Graeber, Thomas G.;
- Agopian, Vatche G.
Publication type:
Article
Efficacy and safety of palbociclib plus endocrine therapy in North American women with hormone receptor‐positive/human epidermal growth factor receptor 2‐negative metastatic breast cancer.
Published in:
Breast Journal, 2020, v. 26, n. 3, p. 368, doi. 10.1111/tbj.13516
By:
- Gelmon, Karen A.;
- Cristofanilli, Massimo;
- Rugo, Hope S.;
- DeMichele, Angela M.;
- Joy, Anil A.;
- Castrellon, Aurelio;
- Sleckman, Bethany;
- Mori, Ave;
- Theall, Kathy Puyana;
- Lu, Dongrui R.;
- Huang, Xin;
- Bananis, Eustratios;
- Finn, Richard S.;
- Slamon, Dennis J.
Publication type:
Article
Characterization of Neutropenia in Advanced Cancer Patients Following Palbociclib Treatment Using a Population Pharmacokinetic-Pharmacodynamic Modeling and Simulation Approach.
Published in:
Journal of Clinical Pharmacology, 2017, v. 57, n. 9, p. 1159, doi. 10.1002/jcph.902
By:
- Sun, Wan;
- O'Dwyer, Peter J.;
- Finn, Richard S.;
- Ruiz‐Garcia, Ana;
- Shapiro, Geoffrey I.;
- Schwartz, Gary K.;
- DeMichele, Angela;
- Wang, Diane
Publication type:
Article
Developing a Treatment Plan for Hepatocellular Carcinoma: The Continuum of Care.
Published in:
Clinical Advances in Hematology & Oncology, 2016, v. 14, p. 9
By:
- Finn, Richard S.
Publication type:
Article
The Role of Liver Biopsy in Hepatocellular Carcinoma.
Published in:
Clinical Advances in Hematology & Oncology, 2016, v. 14, n. 10, p. 759
By:
- Finn, Richard S.
Publication type:
Article
Extending Survival With the Use of Targeted Therapy in the Treatment of Hepatocellular Carcinoma.
Published in:
Clinical Advances in Hematology & Oncology, 2013, v. 11, p. 1
By:
- Gish, Robert G.;
- Finn, Richard S.;
- Marrero, Jorge A.
Publication type:
Article
Extending Survival With the Use of Targeted Therapy for the Treatment of Hepatocellular Carcinoma: Discussion.
Published in:
Clinical Advances in Hematology & Oncology, 2013, v. 11, p. 9
By:
- Gish, Robert G.;
- Finn, Richard S.
Publication type:
Article
Overview and Description of Hepatocellular Carcinoma.
Published in:
Clinical Advances in Hematology & Oncology, 2013, v. 11, p. 4
By:
- Finn, Richard S.
Publication type:
Article
Impact of Dose Reduction on Efficacy: Implications of Exposure-Response Analysis of Palbociclib.
Published in:
Targeted Oncology, 2021, v. 16, n. 1, p. 69, doi. 10.1007/s11523-020-00771-5
By:
- Zheng, Jenny;
- Yu, Yanke;
- Durairaj, Chandrasekar;
- Diéras, Véronique;
- Finn, Richard S.;
- Wang, Diane D.
Publication type:
Article

Found: 59